Wisniewski Raphael 4
4 · Axonics Modulation Technologies, Inc. · Filed Nov 22, 2019
Insider Transaction Report
Form 4
Wisniewski Raphael
Director10% Owner
Transactions
- Sale
Common Stock
2019-11-19$20.73/sh−300,000$6,220,500→ 3,257,461 total(indirect: See footnote)
Footnotes (2)
- [F1]The shares were sold in a public offering pursuant to the Registration Statement of Axonics Modulation Technologies, Inc. on Form S-3 (File No. 333-234546)
- [F2]2,524,128 shares are held of record by BioDiscovery 4 FCPR ("BioDiscovery") and 733,333 shares are held of record by BioDiscovery 5 ("BioDiscovery 5"). Andera Partners ("Andera") is the manager of BioDiscovery and BioDiscovery 5 and may be deemed to have sole voting and dispositive power over the shares held by BioDiscovery and BioDiscovery 5. The reporting person is a director of the Issuer and is a partner of Andera, and may be deemed to share voting and dispositive power over the shares held by BioDiscovery and BioDiscovery 5. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.